Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

The Impact of Atrial Fibrillation on Subsequent Survival of Patients Receiving Ibrutinib As Treatment of Chronic Lymphocytic Leukemia (CLL): An International Study

Philip A Thompson, MBBS, Vincent Levy, MD PhD, Constantine S. Tam, MBBS, Chadi al Nawakil, MD, Francois Xavier Goudot, MD, Anne Quinquenel, MD, Loic Ysebaert, MD PhD, Anne-Sophie Michallet, MD, Marie Sarah Dilhuydy, MD, Eric W Van Den Neste, MD PhD, Jehan Dupuis, MD, Michael Keating, MBBS, Christophe Meune, MD PhD, Florence Cymbalista, MD PhD

Blood (2016) 128 (22): 3242.

https://doi.org/10.1182/blood.V128.22.3242.3242

Published: 2016

Journal Articles

Old DAT / New Data : Positive Direct Antiglobulin Test Identifies a Specific Subgroup Of CLL Patients

Anne Quinquenel, MD, Chadi Al Nawakil, MD, Fanny Baran-Marszak, MD, Virginie Eclache, MD, Remi Letestu, MD, Christine Le Roy, PhD, Nadine Varin-Blank, PhD, Alain Delmer, MD, Vincent Levy, MD, PhD, Florence Cymbalista, MD, PhD

Blood (2013) 122 (21): 4154.

https://doi.org/10.1182/blood.V122.21.4154.4154

Published: 2013

Journal Articles

Association Of More Than One B Cell Clone Arises In Any Type Of Leukemic Chronic B Cell Disorder

Gregory Lazarian, Herve Roudot, Riham Farrah, Chadi Al Nawakil, MD, Remi Letestu, MD, Fanny Baran-Marszak, Virginie Eclache, MD, Marouane Boubaya, Alain Delmer, MD, Vincent Levy, MD, PhD, Florence Cymbalista

Blood (2013) 122 (21): 4161.

https://doi.org/10.1182/blood.V122.21.4161.4161

Published: 2013

Journal Articles

First European Chemotherapy Schedule for Elderly Patients with Acute Lymphoblastic Leukemia: Promising Remission Rate and Feasible Moderate Dose Intensity Consolidation

Nicola Goekbuget, MD, Thibaut Leguay, MD, Mathilde Hunault, MD, Chadi Al-Nawakil, MD, Patrice Chevallier, MD, Herve Dombret, MD, Gisela Fritsch, MD, Albert Oriol, MD, Josep Maria Ribera, MD, Philippe Rousselot, MD, Juan Manuel Sancho, MD, Dieter Hoelzer, MD, PhD

Blood (2008) 112 (11): 304.

https://doi.org/10.1182/blood.V112.11.304.304

Published: 2008

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

The Impact of Atrial Fibrillation on Subsequent Survival of Patients Receiving Ibrutinib As Treatment of Chronic Lymphocytic Leukemia (CLL): An International Study

Old DAT / New Data : Positive Direct Antiglobulin Test Identifies a Specific Subgroup Of CLL Patients

Association Of More Than One B Cell Clone Arises In Any Type Of Leukemic Chronic B Cell Disorder

First European Chemotherapy Schedule for Elderly Patients with Acute Lymphoblastic Leukemia: Promising Remission Rate and Feasible Moderate Dose Intensity Consolidation

Email alerts

ASH Publications

American Society of Hematology

Update search

The Impact of Atrial Fibrillation on Subsequent Survival of Patients Receiving Ibrutinib As Treatment of Chronic Lymphocytic Leukemia (CLL): An International Study

Old DAT / New Data : Positive Direct Antiglobulin Test Identifies a Specific Subgroup Of CLL Patients

Association Of More Than One B Cell Clone Arises In Any Type Of Leukemic Chronic B Cell Disorder

First European Chemotherapy Schedule for Elderly Patients with Acute Lymphoblastic Leukemia: Promising Remission Rate and Feasible Moderate Dose Intensity Consolidation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only